Icon	Function
💬	A pop-up explanation appears when you mouse-over the text beside this icon. Also, an explanation window appears when you click this icon.
	The links beside this icon are links to external sites.
	Clicking this icon sorts the table by the item with this icon (Numerical or alphabetical order). Each click toggles between ascending and descending order.
	A text longer than 100 characters is fully displayed or collapsed.
	The contents of the displayed table are downloaded as a file named "table.csv".

221. Anti-glomerular basement membrane disease Disease details / Clinical trials / Drug dev / DR info /

Clinical trials : 9 / Drugs : 8 - (DrugBank : 4) / Drug target genes : 2 - Drug target pathways : 20

Drugs, Primary sponsors and Trial info (Enrollment year, Phase, Trial ID, Countries)

Cyclophosphamide
   Hansa Biopharma AB
      2022   Phase 3   NCT05679401   Austria;Belgium;Czechia;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
   Shanghai Bao Pharmaceuticals Co., Ltd.
      2024   Phase 2   NCT06607016   China
Eculizumab
   Peking University First Hospital
      2024   Phase 2   NCT06513338   China
Efalizumab
   Merck Serono International S.A.
      2009   -   EUCTR2007-001377-28-PT   Austria;France;Germany;Netherlands;Portugal
      2008   -   EUCTR2007-001377-28-NL   Austria;France;Germany;Netherlands;Portugal
      2008   Phase 4   EUCTR2007-001377-28-FR   Austria;France;Germany;Netherlands;Portugal
      2008   -   EUCTR2007-001377-28-DE   Austria;France;Germany;Netherlands;Portugal
      2008   -   EUCTR2007-001377-28-AT   Austria;France;Germany;Netherlands;Portugal
Glucocorticoids
   Hansa Biopharma AB
      2022   Phase 3   NCT05679401   Austria;Belgium;Czechia;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
   Shanghai Bao Pharmaceuticals Co., Ltd.
      2024   Phase 2   NCT06607016   China
HMED-ides
   Mårten Segelmark
      2017   Phase 2   NCT03157037   Austria;Czechia;Denmark;France;Sweden
Imlifidase
   Hansa Biopharma AB
      2022   Phase 3   NCT05679401   Austria;Belgium;Czechia;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
KJ103 FOR injection
   Shanghai Bao Pharmaceuticals Co., Ltd.
      2024   Phase 2   NCT06607016   China
Raptiva 100 MG/ML powder and solvent FOR solution FOR injection
   Merck Serono International S.A.
      2009   -   EUCTR2007-001377-28-PT   Austria;France;Germany;Netherlands;Portugal
      2008   -   EUCTR2007-001377-28-NL   Austria;France;Germany;Netherlands;Portugal
      2008   Phase 4   EUCTR2007-001377-28-FR   Austria;France;Germany;Netherlands;Portugal
      2008   -   EUCTR2007-001377-28-DE   Austria;France;Germany;Netherlands;Portugal
      2008   -   EUCTR2007-001377-28-AT   Austria;France;Germany;Netherlands;Portugal